Výsledky vyhledávání

Akademický článek

Effects of hydrogen gas inhalation on L-DOPA-induced dyskinesia

Autor: Glauce C. Nascimento, Bruna M. Santos, João F. Pedrazzi, Danyelle Silva-Amaral, Mariza Bortolanza, Grant T. Harris, Elaine Del Bel, Luiz G.S. Branco

Publikováno v: Brain, Behavior, & Immunity - Health, Vol 30, Iss , Pp 100623- (2023)

L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia is a side effect of Parkinson's disease treatment and it is characterized by atypical involuntary movements. A link between neuroinflammation and L-DOPA-induced dyskinesia has been documented.

Externí odkaz: https://doaj.org/article/5d60c4ccdafe4231b392cadb20a1417d

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Aniracetam (Ro 13-5057) for the Treatment of Senile Dementia of Alzheimer Type: Results of a Multicentre Clinical Study

Autor: S. Bonaiuto, Domenico Cucinotta, Giorgio Marini, F. Pedrazzi, Lucilla Parnetti, Franco Erminio, Marco Cuzzupoli, M. Maggioni, Marino Peruzza, Enrico Paciaroni, Umberto Senin, L. Bartorelli

Publikováno v: Dementia and Geriatric Cognitive Disorders. 2:262-267

One hundred and fifteen patients suffering from mild to moderate cognitive impairment fulfilling NINCDS-ADRDA criteria for probable dementia of Alzheimer type were treated for 6 months with a new nootropic drug, aniracetam (Ro 13–5057) in a double-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b5376afe355f11a099a3dd34c01dda26
https://doi.org/10.1159/000107214

Zobrazit plný text záznamu

Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration

Autor: Teresa Cenacchi, T. Bertoldin, C. Farina, M. G. Fiori, G. Crepaldi, C. F. Azzini, R. Girardello, B. Bagozzi, R. Garuti, P. Vivaldi, G. Belloni, A. Bordin, M. Durando, M. Lo Storto, L. Bertoni, A. Battistoni, C. Cacace, P. Arduini, A. Bonini, M. P. Caramia, G. Vaglieri, A. Brusomini, G. Donà, A. March, N. Campi, P. Cannas, F. Casson, G. Cavallarin, M. Delia, G. Cristianini, O. Louvier, F. Mello, R. Fameli, N. Urbani de Gheltoff, O. De Candia, G. Nante, C. Cattoni, P. L. Forte, M. Loreggian, A. Targa, G. Mansoldo, G. Noro, A. Meggio, F. Pedrazzi, F. Bonmartini, C. Ruggiano, M. Peruzza, G. Olivari, E. Recaldin, C. Bellunato, G. Rigo, M. Marin, L. Marinangeli, A. Saracino, O. Miceli, G. Lovo, R. Scarpa, L. Battistello, E. Tomat, B. Bernava, P. Olivo, G. Verga, G. Merli, A. M. Zerman, R. Crivellaro, A. Vozza, G. R. Ziliotto, V. Favaretto, L. Allegro

Publikováno v: Aging (Milan, Italy). 5(2)

This double-blind study assesses the therapeutic efficacy and the safety of oral treatment with phosphatidylserine (BC-PS) vs placebo (300 mg/day for 6 months) in a group of geriatric patients with cognitive impairment. A total of 494 elderly patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08625fdc1e4f46376da225772bf9c7e5
https://pubmed.ncbi.nlm.nih.gov/8323999

Zobrazit plný text záznamu

Multicentre clinical placebo-controlled study with buflomedil in the treatment of mild dementia of vascular origin

Autor: R Terranova, C Franzini, M Capodaglio, Q Granata, P Valdina, F. Pedrazzi, O Ponari, L Bartorelli, Domenico Cucinotta, M A Aveni Casucci, S Reggio, I Toxiri

Publikováno v: The Journal of international medical research. 20(2)

A study was carried out in 73 male or female patients suffering from mild vascular dementia. The experimental protocol involved an initial run-in period (14 days) and subsequent double-blind, randomized treatment with 300 mg buflomedil or placebo giv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e7ad1ea04611561b907bae7a5a4851a
https://pubmed.ncbi.nlm.nih.gov/1521670

Zobrazit plný text záznamu

A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients

Autor: F, Pedrazzi, F, Bommartini, J, Freddo, A, Emanueli

Publikováno v: European journal of rheumatology and inflammation. 4(1)

Phenylbutazone was shown to impair tolbutamide metabolism with resulting potentiation of its hypoglycemic effect and increased danger of hypoglycemia. As indoprofen is widely used for treating rheumatic conditions, and in particular osteoarthritis, t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7c025aa3b352149bd666a4fe8f5369ec
https://pubmed.ncbi.nlm.nih.gov/7042358

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání